Gensight Biologics (France) Price History
SIGHT Stock | EUR 0.31 0.01 3.13% |
If you're considering investing in Gensight Stock, it is important to understand the factors that can impact its price. As of today, the current price of Gensight Biologics stands at 0.31, as last reported on the 27th of November, with the highest price reaching 0.31 and the lowest price hitting 0.29 during the day. Gensight Biologics holds Efficiency (Sharpe) Ratio of -0.0724, which attests that the entity had a -0.0724% return per unit of risk over the last 3 months. Gensight Biologics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Gensight Biologics' Standard Deviation of 4.48, risk adjusted performance of (0.05), and Market Risk Adjusted Performance of (0.36) to validate the risk estimate we provide.
Gensight Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Gensight |
Sharpe Ratio = -0.0724
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | SIGHT |
Estimated Market Risk
4.26 actual daily | 37 63% of assets are more volatile |
Expected Return
-0.31 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.07 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Gensight Biologics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Gensight Biologics by adding Gensight Biologics to a well-diversified portfolio.
Gensight Biologics Stock Price History Chart
There are several ways to analyze Gensight Stock price data. The simplest method is using a basic Gensight candlestick price chart, which shows Gensight Biologics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | October 14, 2024 | 0.42 |
Lowest Price | October 24, 2024 | 0.28 |
Gensight Biologics November 27, 2024 Stock Price Synopsis
Various analyses of Gensight Biologics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Gensight Stock. It can be used to describe the percentage change in the price of Gensight Biologics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Gensight Stock.Gensight Biologics Price Rate Of Daily Change | 0.97 | |
Gensight Biologics Accumulation Distribution | 20,194 | |
Gensight Biologics Price Action Indicator | 0.01 | |
Gensight Biologics Price Daily Balance Of Power | (0.50) |
Gensight Biologics November 27, 2024 Stock Price Analysis
Gensight Stock Price History Data
The price series of Gensight Biologics for the period between Thu, Aug 29, 2024 and Wed, Nov 27, 2024 has a statistical range of 0.17 with a coefficient of variation of 10.49. The price distribution for the period has arithmetic mean of 0.36. The median price for the last 90 days is 0.36.Open | High | Low | Close | Volume | ||
11/26/2024 | 0.31 | 0.31 | 0.29 | 0.31 | 313,014 | |
11/25/2024 | 0.32 | 0.32 | 0.31 | 0.31 | 255,969 | |
11/22/2024 | 0.32 | 0.34 | 0.31 | 0.32 | 416,482 | |
11/21/2024 | 0.31 | 0.32 | 0.31 | 0.32 | 175,721 | |
11/20/2024 | 0.32 | 0.32 | 0.31 | 0.31 | 123,587 | |
11/19/2024 | 0.31 | 0.32 | 0.31 | 0.32 | 64,125 | |
11/18/2024 | 0.34 | 0.34 | 0.31 | 0.31 | 391,705 | |
11/15/2024 | 0.34 | 0.34 | 0.33 | 0.33 | 153,412 | |
11/14/2024 | 0.35 | 0.35 | 0.32 | 0.34 | 394,687 | |
11/13/2024 | 0.32 | 0.37 | 0.31 | 0.34 | 2,218,165 | |
11/12/2024 | 0.32 | 0.32 | 0.30 | 0.31 | 155,068 | |
11/11/2024 | 0.31 | 0.31 | 0.31 | 0.31 | 84,374 | |
11/08/2024 | 0.32 | 0.32 | 0.31 | 0.31 | 116,220 | |
11/07/2024 | 0.31 | 0.32 | 0.31 | 0.32 | 66,165 | |
11/06/2024 | 0.32 | 0.33 | 0.31 | 0.31 | 79,340 | |
11/05/2024 | 0.32 | 0.32 | 0.31 | 0.32 | 103,127 | |
11/04/2024 | 0.32 | 0.33 | 0.31 | 0.32 | 607,701 | |
11/01/2024 | 0.31 | 0.32 | 0.30 | 0.31 | 189,911 | |
10/31/2024 | 0.32 | 0.32 | 0.30 | 0.30 | 129,297 | |
10/30/2024 | 0.32 | 0.32 | 0.32 | 0.32 | 108,096 | |
10/29/2024 | 0.34 | 0.35 | 0.32 | 0.32 | 220,312 | |
10/28/2024 | 0.32 | 0.36 | 0.32 | 0.33 | 711,676 | |
10/25/2024 | 0.36 | 0.37 | 0.30 | 0.30 | 1,156,964 | |
10/24/2024 | 0.28 | 0.29 | 0.28 | 0.28 | 165,991 | |
10/23/2024 | 0.31 | 0.31 | 0.28 | 0.29 | 665,591 | |
10/22/2024 | 0.33 | 0.34 | 0.29 | 0.32 | 761,599 | |
10/21/2024 | 0.35 | 0.37 | 0.33 | 0.34 | 706,884 | |
10/18/2024 | 0.38 | 0.40 | 0.35 | 0.35 | 821,966 | |
10/17/2024 | 0.40 | 0.41 | 0.38 | 0.39 | 351,409 | |
10/16/2024 | 0.41 | 0.43 | 0.40 | 0.40 | 355,374 | |
10/15/2024 | 0.41 | 0.42 | 0.39 | 0.40 | 221,798 | |
10/14/2024 | 0.41 | 0.44 | 0.40 | 0.42 | 984,981 | |
10/11/2024 | 0.37 | 0.39 | 0.37 | 0.39 | 168,272 | |
10/10/2024 | 0.37 | 0.37 | 0.37 | 0.37 | 61,717 | |
10/09/2024 | 0.39 | 0.39 | 0.36 | 0.37 | 70,679 | |
10/08/2024 | 0.36 | 0.39 | 0.36 | 0.38 | 166,376 | |
10/07/2024 | 0.37 | 0.38 | 0.36 | 0.37 | 528,375 | |
10/04/2024 | 0.37 | 0.37 | 0.35 | 0.37 | 176,276 | |
10/03/2024 | 0.37 | 0.37 | 0.35 | 0.36 | 174,425 | |
10/02/2024 | 0.39 | 0.39 | 0.37 | 0.37 | 262,752 | |
10/01/2024 | 0.35 | 0.39 | 0.35 | 0.38 | 606,072 | |
09/30/2024 | 0.34 | 0.35 | 0.34 | 0.35 | 188,824 | |
09/27/2024 | 0.36 | 0.36 | 0.34 | 0.35 | 295,955 | |
09/26/2024 | 0.37 | 0.37 | 0.34 | 0.35 | 90,181 | |
09/25/2024 | 0.37 | 0.37 | 0.35 | 0.36 | 192,786 | |
09/24/2024 | 0.35 | 0.38 | 0.35 | 0.37 | 380,255 | |
09/23/2024 | 0.39 | 0.39 | 0.36 | 0.38 | 388,778 | |
09/20/2024 | 0.39 | 0.40 | 0.37 | 0.39 | 324,131 | |
09/19/2024 | 0.38 | 0.45 | 0.37 | 0.40 | 1,096,165 | |
09/18/2024 | 0.37 | 0.39 | 0.37 | 0.38 | 123,046 | |
09/17/2024 | 0.39 | 0.39 | 0.37 | 0.38 | 85,642 | |
09/16/2024 | 0.39 | 0.39 | 0.38 | 0.39 | 149,946 | |
09/13/2024 | 0.40 | 0.40 | 0.38 | 0.38 | 245,562 | |
09/12/2024 | 0.38 | 0.41 | 0.36 | 0.39 | 691,913 | |
09/11/2024 | 0.37 | 0.40 | 0.36 | 0.38 | 522,864 | |
09/10/2024 | 0.37 | 0.39 | 0.36 | 0.36 | 85,740 | |
09/09/2024 | 0.37 | 0.38 | 0.36 | 0.38 | 72,179 | |
09/06/2024 | 0.38 | 0.38 | 0.35 | 0.37 | 248,031 | |
09/05/2024 | 0.36 | 0.40 | 0.34 | 0.38 | 589,955 | |
09/04/2024 | 0.37 | 0.38 | 0.36 | 0.36 | 266,855 | |
09/03/2024 | 0.38 | 0.39 | 0.37 | 0.38 | 294,120 |
About Gensight Biologics Stock history
Gensight Biologics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Gensight is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Gensight Biologics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Gensight Biologics stock prices may prove useful in developing a viable investing in Gensight Biologics
GenSight Biologics S.A., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies for mitochondrial and neurodegenerative diseases of the eye and central nervous system. GenSight Biologics S.A. was founded in 2012 and is headquartered in Paris, France. GENSIGHT BIOLOGICS is traded on Paris Stock Exchange in France.
Gensight Biologics Stock Technical Analysis
Gensight Biologics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Idea Analyzer Now
Idea AnalyzerAnalyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |
All Next | Launch Module |
Gensight Biologics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Gensight Biologics' price direction in advance. Along with the technical and fundamental analysis of Gensight Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Gensight to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.05) | |||
Jensen Alpha | (0.44) | |||
Total Risk Alpha | (1.03) | |||
Treynor Ratio | (0.37) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Additional Tools for Gensight Stock Analysis
When running Gensight Biologics' price analysis, check to measure Gensight Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gensight Biologics is operating at the current time. Most of Gensight Biologics' value examination focuses on studying past and present price action to predict the probability of Gensight Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gensight Biologics' price. Additionally, you may evaluate how the addition of Gensight Biologics to your portfolios can decrease your overall portfolio volatility.